Annual reports

Eggebø MS, Heinzelbecker J, Palashati H, Chandler N, Tran TT, Li Y, Yang W, Laos M, Blaas I, Rustad EH, Bollineni RC, Delic-Sarac M, Lund-Johansen F, Nielsen MM, Olweus J (2025)
TCR-engineered T cells targeting a shared β-catenin mutation eradicate solid tumors
Nat Immunol (in press)
DOI 10.1038/s41590-025-02252-1, PubMed 40866620

Ullern A, Holm K, Andresen NK, Røssevold AH, Bang C, Naume B, Hov JR, Kyte JA (2025)
Gut microbiota diversity is prognostic in metastatic hormone receptor-positive breast cancer patients receiving chemotherapy and immunotherapy
Mol Oncol (in press)
DOI 10.1002/1878-0261.70117, PubMed 40852937

Foldvari Z, Brennan MS, Titov A, Jacobsen SEW, Olweus J (2025)
Targeting the roots of myeloid malignancies with T cell receptors
Nat Rev Cancer (in press)
DOI 10.1038/s41568-025-00857-0, PubMed 40841587

Sagini K, Selvarajah M, Romero S, Bassols-Citores E, Martin-Gracia B, Ramirez-Garrastacho M, Rise F, Endzeliņš E, Sadovska L, Skorinkina D, Boguševiča M, Cešeiko R, Čampa M, Klavina A, Linē A, Llorente A (2025)
The Redox Enzyme Thioredoxin Is Increased in Plasma Extracellular Vesicles From Endurance-Trained Females in Response to Acute Exercise
FASEB J, 39 (16), e70927
DOI 10.1096/fj.202500678R, PubMed 40810354

Eggebø MS, Heinzelbecker J, Palashati H, Chandler N, Tran TT, Li Y, Yang W, Laos M, Blaas I, Rustad EH, Bollineni RC, Delic-Sarac M, Lund-Johansen F, Nielsen MM, Olweus J (2025)
TCR-engineered T cells targeting a shared β-catenin mutation eradicate solid tumors
Nat Immunol (in press)
DOI 10.1038/s41590-025-02252-1, PubMed 40866620

Mauthe M, van de Beek N, Mari M, Korsten G, Nobari P, Castelino KB, de Mattos EP, Ouhida I, Dijkstra JL, Schipper-Krom S, de la Ballina LR, Mueller MR, Simonsen A, Hipp MS, Kapitein LC, Kampinga HH, Reggiori F (2025)
A chaperone-proteasome-based fragmentation machinery is essential for aggrephagy
Nat Cell Biol (in press)
DOI 10.1038/s41556-025-01747-1, PubMed 40866512